Nilotinib Associated With Increased Peripheral Artery Disease Rate in CML

Two studies found higher rates of peripheral artery occlusive disease in nilotinib-treated chronic myeloid leukemia patients than in imatinib-treated patients.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news